Guide for Authors
Contact
details for submission
Andy Waters
Institute of Biomedical Life Sciences & Wellcome Centre for Molecular
Parasitology,
Division of Infection and Immunity,
Glasgow Biomedical Research Centre, University of Glasgow,
120 University
Place,
Glasgow, Scotland, UK.
E-mail:
Waters@bio.gla.ac.uk
Phil LoVerde
University of Texas,
Departments
of Biochemistry and Pathology,
Mail Code 7760, Health Science Center,
San Antonio, Texas 78229-3900, USA.
Email:
loverde@uthscsa.edu
Marilyn. Parsons
Seattle Biomedical Research Institute,
307 Westlake Avenue, N, Suite 500,
Seattle, WA 98109-5219,
USA.
Email:
marilyn.parsons@sbri.org
Keith Matthews
University of Edinburgh, Institute of Immunology
and Infection Research,
School of Biological Sciences,
Ashworth Laboratories, West Mains Road,
Edinburgh, EH9 3JT, Scotland,
UK.
Email:
keith.matthews@ed.ac.uk
Reviews Editor
Alister Craig
Liverpool School of Tropical
Medicine,
Pembroke Place, Liverpool L3 5QA, UK.
E-mail:
agcraig@liverpool.ac.uk
Ethics in publishing
For information on Ethics in publishing and Ethical guidelines
for journal publication see
http://www.elsevier.com/publishingethics and
http://www.elsevier.com/ethicalguidelines.
Policy and ethics
Ethics of experimentation
Submitted papers must contain precise details on the
care and use of animals and of experimental procedures, especially interventions such as surgery and tissue sampling, and methods of
euthanasia. Authors are expected to comply with all relevant institutional and governmental policies, regulations, and guidelines regarding
the ethical treatment of experimental animals. Authors should record their compliance with such policies, regulations, and guidelines,
as implemented under protocols developed by the relevant institution(s) with which authors are affiliated, in the Methods section of
their manuscripts. The editors reserve the right to request documentation of such compliance. If experimental animals are used for growth
of parasites when an in vitro culture system is available for the species in question, a specific justification for this must be provided.
Furthermore, referees are asked to indicate whether there is any reason to consider that experimental animals were used unnecessarily,
not well treated or care was not taken to avoid distress. Papers may ultimately be rejected upon such grounds.
Conflict
of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately
influence, or be perceived to influence, their work. See also
http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously
(except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any
other language, without the written consent of the copyright-holder.
Submission declaration and verification
Submission
of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published
lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors
and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published
elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.
To verify originality, your article may be checked by the originality detection software iThenticate. See also
http://www.elsevier.com/editors/plagdetect.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the
authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove
an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript
and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail,
fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded
by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers
will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until
authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or
rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement'
(for more information on this and copyright see
http://www.elsevier.com/copyright). Acceptance of the agreement will ensure
the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript
together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce
tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of
the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations
and translations (please consult
http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included,
the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted
forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained
author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred to:
http://www.elsevier.com/authorsrights.
Role of the funding source
You are requested
to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe
the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report;
and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Please see
http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier
has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply
with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements
and policies please visit
http://www.elsevier.com/fundingbodies.
Open access
This
journal offers you the option of making your article freely available to all via the ScienceDirect platform. To prevent any conflict
of interest, you can only make this choice after receiving notification that your article has been accepted for publication. The fee
of $3,000 excludes taxes and other potential author fees such as color charges. In some cases, institutions and funding bodies have entered
into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements are available at
http://www.elsevier.com/fundingbodies.
Authors of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf).
Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your
article on your own website. More information can be found here:
http://www.elsevier.com/authorsrights.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit
http://webshop.elsevier.com/languageservices
or our customer support site at
http://support.elsevier.com
for more information.
Referees
Please submit, with the manuscript, the names, addresses
and e-mail addresses of three potential referees. Note that the editor retains the sole right to decide whether or not the suggested
reviewers are used.
Additional information
Publication in Molecular and Biochemical Parasitology
is taken to imply the authors' willingness to comply with reasonable requests to supply reagents such as recombinant clones and monoclonal
antibodies, and sequence data in electronic form to persons lacking access to computer databases.
Distribution of Materials and
Data
One of the terms and conditions of publishing in Molecular and Biochemical Parasitology is that authors be willing to distribute
any materials and protocols used in the published experiments to qualified researchers for their own reasonable use. Materials include
but are not limited to cells, DNA, antibodies, reagents, vectors, constructs, organisms, and mouse strains. If quantities allow, these
must be made available with minimal restrictions and in a timely manner, but it is acceptable to request reasonable payment to cover
the cost of maintenance and transport of materials. If there are restrictions to the availability of any materials, data, or information,
these must be disclosed in the cover letter and the Materials and Methods section of the manuscript at the time of submission.
Authors who produce reagents that are suitable for the study of malaria parasites are strongly encouraged to deposit these with the
Malaria Research and Reference Reagent Resource Center [
www.MR4.org].
Use of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor
used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed
and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words.
However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one
grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic
text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication).
Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also
the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your wordprocessor.
Article structure
Subdivision - numbered
sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1,
1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do
not just refer to 'the text'. Any subsection may be given a brief heading. Each heading should appear on its own separate line.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature
survey or a summary of the results.
Material and methods
Provide sufficient detail to allow
the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.
Results
Results should be clear and concise.
Discussion
This
should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate.
Avoid extensive citations and discussion of published literature.
Conclusions
The main conclusions
of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and
Discussion section.
Appendices
If there is more than one appendix, they should be identified
as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix,
Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
Essential title page
information
•
Title.
Concise and informative. Titles are often used in information-retrieval systems.
Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name may be
ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was
done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front
of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail
address of each author.
•
Corresponding author.
Clearly indicate who will handle correspondence at all stages
of refereeing and publication, also post-publication.
Ensure that telephone and fax numbers (with country and area code) are provided
in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.
•
Present/permanent address.
If an author has moved since the work described in the article was done, or was visiting at
the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the
author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A concise and factual abstract is required. The abstract should state briefly the purpose of the
research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able
to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard
or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Graphical abstract
NOTE regarding the mandatory Graphical Abstract:
The Graphical Abstract should allow
readers to quickly gain an understanding of the main take-home message of the paper and is intended to encourage browsing, promote interdisciplinary
scholarship, and help readers identify more quickly which papers are most relevant to their research interests. It should summarise the
contents of the paper in a concise, pictorial form designed to capture the attention of a wide readership online. Authors must provide
images that clearly represent the work described in the paper. Graphical abstracts should be uploaded as an individual/separate file.
The graphical abstract should comprise the title, authors and affiliations, identical to the article itself, a summary of about 25 words,
and a pictogram [one figure representative of the work described]. Graphical abstracts will be collated to provide a contents list for
rapid scanning. Ideally, the graphical abstract should be uploaded in full colour rather than in black and white, to make it as visually
interesting as possible. While a key, summarising figure taken from the original paper can be submitted as a graphical abstract, it should
be noted that it does not need to be an image from the manuscript itself.
Specifications for Graphical Abstracts
- Maximum
image size 400x600 pixels (hxw, recommended size 200 x 500 pixels
- Use Arial font with a size of 10-16 points
- Preferred
file types TIFF, EPS, PDF or MS Office files
- Visualise one process or make one point clear
- For ease of browsing,
images should have a clear start and end, ideally "reading" from top to bottom or left to right
- Avoid distracting
graphics or cluttered material as much as possible.
See
http://www.elsevier.com/graphicalabstracts for examples.
NOTE: The cover images of future issues will be selected from the graphical abstracts of the papers within that issue.
Highlights
Highlights are mandatory for this journal. They consist of a short collection of bullet points
that convey the core findings of the article and should be submitted in a separate file in the online submission system. Please use 'Highlights'
in the file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point). See
http://www.elsevier.com/highlights
for examples.
Keywords
Immediately after the abstract, provide a maximum of 6 keywords,
using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with
abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first
page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as
in the footnote. Ensure consistency of abbreviations throughout the article.
Abbreviations, symbols, chemical
and biochemical nomenclature, etc., should follow the recommendations given in the Journal of Biological Chemistry (Vol. 272, pp. 28165-28170;
http://www.jbc.org). Avoid abbreviations which are not in common use across the field of molecular and biochemical parasitology.
Those used should be defined in the text on first usage and listed as a footnote on the title page. Do not introduce abbreviations unless
they are used at least 4 times.
Genetic nomenclature for Trypanosoma and Leishmania should follow the guidelines proposed by
Clayton et al (1998), Mol Biochem Parasitol 1998;97:221-224
http://www.elsevier.com/inca/publications/misc/MOLBIO_97_1-2.pdf
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references
and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided
help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).
Database
linking
Elsevier aims at connecting online articles with external databases which are useful in their respective research
communities. If your article contains relevant unique identifiers or accession numbers (bioinformatics) linking to information on entities
(genes, proteins, diseases, etc.) or structures deposited in public databases, then please indicate those entities according to the standard
explained below.
Authors should explicitly mention the
database abbreviation (as mentioned below) together with the actual database
number, bearing in mind that an error in a letter or number can result in a dead link in the online version of the article.
Please
use the following format:
Database ID: xxxx
Links can be provided in your online article to the following databases (examples
of citations are given in parentheses):
•
ASTM: ASTM Standards Database
(ASTM ID: G63)
•
CCDC: Cambridge Crystallographic Data Centre
(CCDC ID: AI631510)
•
GenBank: Genetic sequence database
at the National Center for Biotechnology Information (NCBI) (GenBank ID: BA123456)
•
GEO:
Gene Expression Omnibus (GEO ID: GSE27196; GEO ID: GPL5366; GEO ID: GSM9853)
•
MI:
EMBL-EBI OLS Molecular Interaction Ontology (MI ID: 0218)
•
MINT:
Molecular INTeractions database (MINT ID: 6166710)
•
NCBI Taxonomy:
NCBI Taxonomy Browser (NCBI Taxonomy ID: 48184)
•
NCT: ClinicalTrials.gov
(NCT ID: NCT00222573)
•
OMIM: Online Mendelian Inheritance
in Man (OMIM ID: 601240)
•
PDB: Worldwide Protein Data
Bank (PDB ID: 1TUP)
•
TAIR: The Arabidopsis Information Resource
database (TAIR ID: AT1G01020)
•
UniProt: Universal Protein Resource
Knowledgebase (UniProt ID: Q9H0H5)
Footnotes
Footnotes should be used sparingly. Number
them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this
feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves
separately at the end of the article. Do not include footnotes in the Reference list.
Table footnotes
Indicate each
footnote in a table with a superscript lowercase letter.
Artwork
Electronic
artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
•
Save text in illustrations as 'graphics' or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier,
Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention
for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of
the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our
website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the
detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is
finalised, please 'save as' or convert the images to one of the following formats (note the resolution requirements for line drawings,
halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as 'graphics'.
TIFF:
Color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000
dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
If your electronic artwork
is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.
Please do not:
•
Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are
too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color
artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct
resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge,
that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations
are reproduced in color in the printed version.
For color reproduction in print, you will receive information regarding the costs
from Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or on the Web only. For
further information on the preparation of electronic artwork, please see
http://www.elsevier.com/artworkinstructions.
Please
note: Because of technical complications which can arise by converting color figures to 'gray scale' (for the printed version should
you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the
figure. A caption should comprise a brief title (
not on the figure itself) and a description of the illustration. Keep text in
the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number
tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them
with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables
do not duplicate results described elsewhere in the article.
References
Citation
in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any
references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference
list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference
style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'.
Citation of a reference as 'in press' implies that the item has been accepted for publication.
Web references
As
a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author
names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the
reference list) under a different heading if desired, or can be included in the reference list.
References
in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations
in the text) to other articles in the same Special Issue.
Reference style
Text:
Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s)
must always be given.
List: Number the references (numbers in square brackets) in the list in the order in which they appear
in the text.
Examples:
Reference to a journal publication:
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art
of writing a scientific article. J Sci Commun 2010;163:51–9.
Reference to a book:
[2] Strunk Jr W, White EB. The elements
of style. 4th ed. New York: Longman; 2000.
Reference to a chapter in an edited book:
[3] Mettam GR, Adams LB. How to prepare
an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc;
2009, p. 281–304.
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors the first 6
should be listed followed by 'et al.' For further details you are referred to 'Uniform Requirements for Manuscripts submitted to Biomedical
Journals' (J Am Med Assoc 1997;277:927–34) (see also
http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Video data
Elsevier
accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files
that they wish to submit with their article are strongly encouraged to include these within the body of the article. This can be done
in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed.
All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your
video or animation material is directly usable, please provide the files in one of our recommended file formats with a preferred maximum
size of 50 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web
products, including ScienceDirect:
http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose
any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the
link to your video data. For more detailed instructions please visit our video instruction pages at
http://www.elsevier.com/artworkinstructions.
Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and
the print version for the portions of the article that refer to this content.
Supplementary data
Elsevier
accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional
possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Supplementary files
supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please provide the data
in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply
a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Submission checklist
It is hoped that this list will be useful during the final checking of an article prior
to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure
that the following items are present:
* One Author designated as corresponding Author [with e-mail address, full postal address,
telephone and fax numbers]
* All necessary files have been uploaded [including source files of figures]
* Keywords
* All
figure legends
* All tables (including title, description, footnotes)
* Graphical abstract
* Systematic IDs for genes/proteins
studied
* Accession numbers for sequences deposited or used, databases such as GEO as relevant.
Further considerations:
* Line numbers and page numbers throughout the manuscript
* Manuscript has been "spellchecked" and "grammar-checked"
* Line
spacing: The main manuscript should be double-spaced but the reference section, tables and figure legends should be single-spaced
* References are in the correct format for this journal
* All references mentioned in the Reference list are cited in the text,
and vice versa
* Permission has been obtained for use of copyrighted material from other sources (including the Web)
* Figures
are in a format that is acceptable for publication as detailed in the Guide for Authors
* Color figures are clearly marked as being
intended for color reproduction both on the Web (free of charge) and in print [for a fee] or to be reproduced in color on the Web (free
of charge) and in black-and-white in print. Note that current charges for colour reproduction in print are set at USD 200 / 150 Euro
per figure but these costs are subject to change. You will receive the exact price if/when your manuscript is accepted into production
* If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes.
Additional information
Short communications and Technical Reports
These are intended for the
publication of brief definitive reports, sequence data, methods, biochemical or immunochemical data that do not merit a full-length publication.
Short communications have similar subject scope to the full-length papers, while short technical reports concern mainly methods and reports
of completed DNA sequencing projects.
Short communications and short technical reports are no more than four pages long including
everything, with maximally two figures, one table and a maximum of 20 references. A single page contains about 900 words. Only the salient
points of a long DNA sequence should be published, as the whole sequence will be available for a computer database. The title, authorship,
affiliations, and an abstract not exceeding 150 words will be in the standard format of the journal. The text should not be sectioned,
except for references. Essential experimental details may be incorporated into a figure legend. To facilitate rapid publication, authors
will be expected to supply high-quality copy and expedite any necessary revisions.
Minireviews
Minireviews are
by invitation only. Potential topics of general current interest should be submitted to the senior editor for consideration. Reviews
should be short, current, specific and potentially provocative. They should provide a balanced synthesis from the available data rather
than a comprehensive regurgitation of the literature. If possible, they should provide new concepts and ideas extending across different
parasite systems. Reviews are restricted to about 4000 words, at most three display items including figures and tables and a list of
references of not more than 50. The text can be divided into simple subsections with a succinct abstract. Minireviews will undergo the
established review process at MBP, and will be published by an accelerated schedule if accepted.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may
be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a
document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for
citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The correct
format for citing a DOI is shown as follows (example taken from a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2010.09.059
When you use the DOI to create URL hyperlinks to documents on the web, the DOIs are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download
the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe
Reader version 7 (or higher) available free from
http://get.adobe.com/reader. Instructions on how to annotate PDF files
will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark
the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the
pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text,
tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately – please let us have all your
corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: please check carefully
before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that
Elsevier may proceed with the publication of your article if no response is received.
Offprints
The
corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra charge, paper offprints can
be ordered via the offprint order form which is sent once the article is accepted for publication. The PDF file is a watermarked version
of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions
of use.
For inquiries relating to the submission of articles (including
electronic submission) please visit this journal's homepage. Contact details for questions arising after acceptance of an article, especially
those relating to proofs, will be provided by the publisher. You can track accepted articles at
http://www.elsevier.com/trackarticle.
You can also check our Author FAQs (
http://www.elsevier.com/authorFAQ) and/or contact Customer Support via
http://support.elsevier.com.
